EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 35 / Numéro 8-9 (Août–Septembre 2019) Med Sci (Paris), 35 8-9 (2019) 674-681 Références
Open Access
Numéro
Med Sci (Paris)
Volume 35, Numéro 8-9, Août–Septembre 2019
Page(s) 674 - 681
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2019127
Publié en ligne 18 septembre 2019
  1. Dodd S.. Current insights in the placebo and nocebo phenomena. Clin Ther 2017 ; 39 : 456–457. [PubMed] [Google Scholar]
  2. Rief W, Bingel U, Schedlowski M, Enck P. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin Pharmacol Ther 2011 ; 90 : 722–726. [CrossRef] [PubMed] [Google Scholar]
  3. Hahn RA. The nocebo phenomenon: concept, evidence, and implications for public health. Prev Med 1997 ; 26 : 607–611. [CrossRef] [PubMed] [Google Scholar]
  4. Wolf S.. Effects of suggestion and conditioning on the action of chemical agents in human subjects: the pharmacology of placebos. J Clin Invest 1950 ; 29 : 100–109. [CrossRef] [PubMed] [Google Scholar]
  5. Autret A. Les effets placebo des relations entre croyances et médecines. Paris: L’Harmattan, 2013: 112 p [Google Scholar]
  6. Lemoine P. Le mystère du placebo. Paris: Odile Jacob, 2006: 238 p [Google Scholar]
  7. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010 Jan 20; (1) : CD003974. [Google Scholar]
  8. Colagiuri B, Schenk LA, Kessler MD, et al. The placebo effect: from concepts to genes. Neuroscience 2015 ; 307 : 171–190. [PubMed] [Google Scholar]
  9. Wartolowska KA, Feakins BG, Collins GS, et al. The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis. Trials 2016 ; 17 : 589. [Google Scholar]
  10. Cragg JJ, Warner FM, Finnerup NB, et al. Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics. Pain 2016 ; 157 : 530–540. [CrossRef] [PubMed] [Google Scholar]
  11. Thomas KB. General practice consultations: is there any point in being positive?. Br Med J Clin Res Ed 1987 ; 294 : 1200–1202. [CrossRef] [PubMed] [Google Scholar]
  12. Turner JA. The importance of placebo effects in pain treatment and research. JAMA 1994 ; 271 : 1609. [CrossRef] [PubMed] [Google Scholar]
  13. Meissner K, Fässler M, Rücker G, et al. Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis. JAMA Intern Med 2013 ; 173 : 1941. [CrossRef] [PubMed] [Google Scholar]
  14. Kaptchuk TJ. Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing. Philos Trans R Soc Lond B Biol Sci 2011 ; 366 : 1849–1858. [CrossRef] [PubMed] [Google Scholar]
  15. Kerr CE, Shaw JR, Conboy LA, et al. Placebo acupuncture as a form of ritual touch healing: a neurophenomenological model. Conscious Cogn 2011 ; 20 : 784–791. [CrossRef] [PubMed] [Google Scholar]
  16. Geuter S, Koban L, Wager TD. The cognitive neuroscience of placebo effects: Concepts, predictions, and physiology. Annu Rev Neurosci 2017 ; 40 : 167–188. [CrossRef] [PubMed] [Google Scholar]
  17. Wager TD. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004 ; 303 : 1162–1167. [Google Scholar]
  18. Schafer SM, Colloca L, Wager TD. Conditioned placebo analgesia persists when subjects know they are receiving a placebo. J Pain 2015 ; 16 : 412–420. [Google Scholar]
  19. de la Fuente-Fernandez R.. Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science 2001 ; 293 : 1164–1166. [Google Scholar]
  20. Hall KT, Lembo AJ, Kirsch I, et al. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One 2012 ; 7 : e48135. [CrossRef] [PubMed] [Google Scholar]
  21. Tacheau M, Reny J, Crépin E, et al. Le placebo a-t-il sa place dans la relation soignant-soigné à l’hôpital ?. Éthique et Santé 2017 ; 14 : 4–10. [Google Scholar]
  22. Hawke K, van Driel ML, Buffington BJ, et al. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children. Cochrane Database Syst Rev 2018; 9 : CD005974. [PubMed] [Google Scholar]
  23. Sherman R, Hickner J. Academic physicians use placebos in clinical practice and believe in the mind–body connection. J Gen Intern Med 2008 ; 23 : 7–10. [Google Scholar]
  24. Berthelot JM, Maugars Y, Abgrall M, Prost A. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Jt Bone Spine Rev Rhum 2001 ; 68 : 65–70. [CrossRef] [Google Scholar]
  25. Fässler M, Meissner K, Schneider A, Linde K. Frequency and circumstances of placebo use in clinical practice: a systematic review of empirical studies. BMC Med 2010 ; 8 : 15. [CrossRef] [PubMed] [Google Scholar]
  26. Haour F.. Mécanismes de l’effet placebo et du conditionnement : Données neurobiologiques chez l’homme et l’animal. Med Sci (Paris) 2005 ; 21 : 315–319. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  27. Bouhassira D. L’anti-douleur. Paris: Le Cherche-Midi, 2018: 208 p [Google Scholar]
  28. Guess HA. The science of the placebo: toward an interdisciplinary research agenda. Londres: BMJ Books, 2002: 332 p [Google Scholar]
  29. Kong J, Spaeth R, Cook A, et al. Are all placebo effects equal? Placebo pills, sham acupuncture, cue conditioning and their association. PLoS One 2013 ; 8 : e67485. [CrossRef] [PubMed] [Google Scholar]
  30. Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 2005 ; 114 : 3–6. [CrossRef] [PubMed] [Google Scholar]
  31. Vital Durand D, Fassier T. Peut-on étudier scientifiquement le placebo ? Médecine Thérapeutique 2010; 16 : 252–8. [Google Scholar]
  32. de Craen AJ, Tijssen JG, de Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000 ; 247 : 183–188. [CrossRef] [PubMed] [Google Scholar]
  33. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects?. J Clin Epidemiol 2000 ; 53 : 786–792. [CrossRef] [PubMed] [Google Scholar]
  34. Schaefer M, Sahin T, Berstecher B. Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis. PLoS One 2018 ; 13 : e0192758. [CrossRef] [PubMed] [Google Scholar]
  35. Locher C, Frey Nascimento A, Kirsch I, et al. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Pain 2017 ; 158 : 2320–2328. [CrossRef] [PubMed] [Google Scholar]
  36. Kaptchuk TJ, Friedlander E, Kelley JM, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010 ; 5 : e15591. [CrossRef] [PubMed] [Google Scholar]
  37. Carvalho C, Caetano JM, Cunha L, et al. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain 2016 ; 157 : 2766–2772. [CrossRef] [PubMed] [Google Scholar]
  38. Jordan B.. Cancer : thérapies « complémentaires » et observance du traitement anti-tumoral font-elles bon ménage ?. Med Sci (Paris) 2018 ; 34 : 999–1002. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.